The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Giant Cell Arteritis Treatment-Global Market Insights and Sales Trends 2024
Synopsis
Giant cell arteritis is also known as temporal arteritis, is a type of disease which causes inflammation of medium and large vessels that occurs only in individuals older than 50 years of age.
The global Giant Cell Arteritis Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Giant Cell Arteritis Treatment in various end use industries. The expanding demands from the Hospitals, Clinics, ASCs and Others, are propelling Giant Cell Arteritis Treatment market. Corticosteroid Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Adjuvant Agents segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Giant Cell Arteritis Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Giant Cell Arteritis Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Giant Cell Arteritis Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Giant Cell Arteritis Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Giant Cell Arteritis Treatment covered in this report include Johns Hopkins Hospital, Fortis Healthcare, American College of Rheumatology, Duke University Health System and Lahey Clinic Foundation, etc.
The global Giant Cell Arteritis Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Johns Hopkins Hospital
Fortis Healthcare
American College of Rheumatology
Duke University Health System
Lahey Clinic Foundation
Global Giant Cell Arteritis Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Giant Cell Arteritis Treatment market, Segment by Type:
Corticosteroid Therapy
Adjuvant Agents
Global Giant Cell Arteritis Treatment market, by Application
Hospitals
Clinics
ASCs
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Giant Cell Arteritis Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Giant cell arteritis is also known as temporal arteritis, is a type of disease which causes inflammation of medium and large vessels that occurs only in individuals older than 50 years of age.
The global Giant Cell Arteritis Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Giant Cell Arteritis Treatment in various end use industries. The expanding demands from the Hospitals, Clinics, ASCs and Others, are propelling Giant Cell Arteritis Treatment market. Corticosteroid Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Adjuvant Agents segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Giant Cell Arteritis Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Giant Cell Arteritis Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Giant Cell Arteritis Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Giant Cell Arteritis Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Giant Cell Arteritis Treatment covered in this report include Johns Hopkins Hospital, Fortis Healthcare, American College of Rheumatology, Duke University Health System and Lahey Clinic Foundation, etc.
The global Giant Cell Arteritis Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Johns Hopkins Hospital
Fortis Healthcare
American College of Rheumatology
Duke University Health System
Lahey Clinic Foundation
Global Giant Cell Arteritis Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Giant Cell Arteritis Treatment market, Segment by Type:
Corticosteroid Therapy
Adjuvant Agents
Global Giant Cell Arteritis Treatment market, by Application
Hospitals
Clinics
ASCs
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Giant Cell Arteritis Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Giant Cell Arteritis Treatment
1.1 Giant Cell Arteritis Treatment Market Overview
1.1.1 Giant Cell Arteritis Treatment Product Scope
1.1.2 Giant Cell Arteritis Treatment Market Status and Outlook
1.2 Global Giant Cell Arteritis Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Giant Cell Arteritis Treatment Market Size by Region (2018-2029)
1.4 Global Giant Cell Arteritis Treatment Historic Market Size by Region (2018-2023)
1.5 Global Giant Cell Arteritis Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Giant Cell Arteritis Treatment Market Size (2018-2029)
1.6.1 North America Giant Cell Arteritis Treatment Market Size (2018-2029)
1.6.2 Europe Giant Cell Arteritis Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Giant Cell Arteritis Treatment Market Size (2018-2029)
1.6.4 Latin America Giant Cell Arteritis Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Giant Cell Arteritis Treatment Market Size (2018-2029)
2 Giant Cell Arteritis Treatment Market by Type
2.1 Introduction
2.1.1 Corticosteroid Therapy
2.1.2 Adjuvant Agents
2.2 Global Giant Cell Arteritis Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Giant Cell Arteritis Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Giant Cell Arteritis Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Giant Cell Arteritis Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Giant Cell Arteritis Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Giant Cell Arteritis Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Giant Cell Arteritis Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Giant Cell Arteritis Treatment Revenue Breakdown by Type (2018-2029)
3 Giant Cell Arteritis Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 ASCs
3.1.4 Others
3.2 Global Giant Cell Arteritis Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Giant Cell Arteritis Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Giant Cell Arteritis Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Giant Cell Arteritis Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Giant Cell Arteritis Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Giant Cell Arteritis Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Giant Cell Arteritis Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Giant Cell Arteritis Treatment Revenue Breakdown by Application (2018-2029)
4 Giant Cell Arteritis Treatment Competition Analysis by Players
4.1 Global Giant Cell Arteritis Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Giant Cell Arteritis Treatment as of 2022)
4.3 Date of Key Players Enter into Giant Cell Arteritis Treatment Market
4.4 Global Top Players Giant Cell Arteritis Treatment Headquarters and Area Served
4.5 Key Players Giant Cell Arteritis Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Giant Cell Arteritis Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Johns Hopkins Hospital
5.1.1 Johns Hopkins Hospital Profile
5.1.2 Johns Hopkins Hospital Main Business
5.1.3 Johns Hopkins Hospital Giant Cell Arteritis Treatment Products, Services and Solutions
5.1.4 Johns Hopkins Hospital Giant Cell Arteritis Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Johns Hopkins Hospital Recent Developments
5.2 Fortis Healthcare
5.2.1 Fortis Healthcare Profile
5.2.2 Fortis Healthcare Main Business
5.2.3 Fortis Healthcare Giant Cell Arteritis Treatment Products, Services and Solutions
5.2.4 Fortis Healthcare Giant Cell Arteritis Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Fortis Healthcare Recent Developments
5.3 American College of Rheumatology
5.3.1 American College of Rheumatology Profile
5.3.2 American College of Rheumatology Main Business
5.3.3 American College of Rheumatology Giant Cell Arteritis Treatment Products, Services and Solutions
5.3.4 American College of Rheumatology Giant Cell Arteritis Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Duke University Health System Recent Developments
5.4 Duke University Health System
5.4.1 Duke University Health System Profile
5.4.2 Duke University Health System Main Business
5.4.3 Duke University Health System Giant Cell Arteritis Treatment Products, Services and Solutions
5.4.4 Duke University Health System Giant Cell Arteritis Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Duke University Health System Recent Developments
5.5 Lahey Clinic Foundation
5.5.1 Lahey Clinic Foundation Profile
5.5.2 Lahey Clinic Foundation Main Business
5.5.3 Lahey Clinic Foundation Giant Cell Arteritis Treatment Products, Services and Solutions
5.5.4 Lahey Clinic Foundation Giant Cell Arteritis Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Lahey Clinic Foundation Recent Developments
6 North America
6.1 North America Giant Cell Arteritis Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Giant Cell Arteritis Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Giant Cell Arteritis Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Giant Cell Arteritis Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Giant Cell Arteritis Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Giant Cell Arteritis Treatment Market Dynamics
11.1 Giant Cell Arteritis Treatment Industry Trends
11.2 Giant Cell Arteritis Treatment Market Drivers
11.3 Giant Cell Arteritis Treatment Market Challenges
11.4 Giant Cell Arteritis Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
